GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Equasens (CHIX:EQSp) » Definitions » EV-to-EBIT

Equasens (CHIX:EQSP) EV-to-EBIT : 31.56 (As of Apr. 26, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Equasens EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Equasens's Enterprise Value is €888.8 Mil. Equasens's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was €28.2 Mil. Therefore, Equasens's EV-to-EBIT for today is 31.56.

The historical rank and industry rank for Equasens's EV-to-EBIT or its related term are showing as below:

CHIX:EQSp' s EV-to-EBIT Range Over the Past 10 Years
Min: 8.05   Med: 19.99   Max: 39.64
Current: 31.55

During the past 13 years, the highest EV-to-EBIT of Equasens was 39.64. The lowest was 8.05. And the median was 19.99.

CHIX:EQSp's EV-to-EBIT is ranked worse than
76.46% of 429 companies
in the Healthcare Providers & Services industry
Industry Median: 18.61 vs CHIX:EQSp: 31.55

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Equasens's Enterprise Value for the quarter that ended in Jun. 2023 was €1,266.0 Mil. Equasens's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was €28.2 Mil. Equasens's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 was 2.22%.


Equasens EV-to-EBIT Historical Data

The historical data trend for Equasens's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Equasens EV-to-EBIT Chart

Equasens Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.51 36.39 27.33 20.49 -

Equasens Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.33 - 20.49 - -

Competitive Comparison of Equasens's EV-to-EBIT

For the Health Information Services subindustry, Equasens's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Equasens's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Equasens's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Equasens's EV-to-EBIT falls into.



Equasens EV-to-EBIT Calculation

Equasens's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=888.792/28.164
=31.56

Equasens's current Enterprise Value is €888.8 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Equasens's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was €28.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Equasens  (CHIX:EQSp) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Equasens's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2023 ) =EBIT / Enterprise Value (Q: Jun. 2023 )
=28.164/1266.00353
=2.22 %

Equasens's Enterprise Value for the quarter that ended in Jun. 2023 was €1,266.0 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Equasens's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was €28.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Equasens EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Equasens's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Equasens (CHIX:EQSP) Business Description

Traded in Other Exchanges
Address
5 Allee de Saint-Cloud, Technopole de Nancy Brabois, Villers-les-Nancy, FRA, 54600
Equasens is engaged in the European healthcare sector, providing software solutions to all healthcare professionals (pharmacists, primary care practitioners, hospitals, Hospital-at-Home structures, retirement homes, health centres) and patients in both primary and secondary care sectors. With operations in France, Italy, Belgium, Luxembourg and the United Kingdom, Equasens is developing the healthcare platform and an ecosystem in France and Europe benefiting people by making available its technology services.

Equasens (CHIX:EQSP) Headlines

No Headlines